Skip to main content
. 2020 May 5;5(19):10878–10890. doi: 10.1021/acsomega.0c00529

Figure 6.

Figure 6

Ginsenoside Rg1 obviously promoted the expression of CPT1A2 in the animal models of NAFLD. (A) Ginsenoside Rg1 obviously promoted the mRNA expression of CPT1A. The mRNA expression was detected by q-PCR after ginsenoside Rg1 treatment for 4 or 8 weeks. (B, C) Ginsenoside Rg1 obviously promoted the protein expression of CPT1A. The protein expression was detected by immunohistochemical and western blot assay after ginsenoside Rg1 treatment for 4 or 8 weeks. The values shown are mean ± SEM of the data from three independent experiments. #Significant compared with the control group alone, P < 0.05; *significant compared with the model group alone, P < 0.05; @significant compared with simvastatin alone, P < 0.05.